ESSA Pharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch ESSA Pharma and buy or sell other stocks, ETFs, and their options commission-free!About EPIX
ESSA Pharma, Inc. is a clinical stage pharmaceutical company. It engages in the business of developing small molecule drugs for the treatment of prostate cancer.
CEODavid R. Parkinson, MD, PhD
CEODavid R. Parkinson, MD, PhD
Employees35
Employees35
HeadquartersVancouver, British Columbia
HeadquartersVancouver, British Columbia
Founded2009
Founded2009
Employees35
Employees35
EPIX Key Statistics
Market cap8.93M
Market cap8.93M
Price-Earnings ratio-0.35
Price-Earnings ratio-0.35
Dividend yield—
Dividend yield—
Average volume1.40M
Average volume1.40M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$6.11
52 Week high$6.11
52 Week low$0.18
52 Week low$0.18
Stock Snapshot
With a market cap of 8.93M, ESSA Pharma(EPIX) trades at $0.20. The stock has a price-to-earnings ratio of -0.35.
On 2025-12-05, ESSA Pharma(EPIX) stock opened at —, reached a high of —, and a low of —.
The ESSA Pharma(EPIX)'s current trading volume is 0, compared to an average daily volume of 1.4M.
In the last year, ESSA Pharma(EPIX) shares hit a 52-week high of $6.11 and a 52-week low of $0.18.
In the last year, ESSA Pharma(EPIX) shares hit a 52-week high of $6.11 and a 52-week low of $0.18.
People also own
Based on the portfolios of people who own EPIX. This list is generated using Robinhood data, and it’s not a recommendation.